Press release from TC TECH Sweden AB’s 2022 Annual General Meeting
TC TECH Sweden AB’s Annual General Meeting was held today, May 19, 2022, adjacent to the company’s own premises at Pirgatan 13 in Karlshamn, Sweden. Approximately 47,4% of all issued shares were represented at the AGM.
The AGM approved the income statement and the balance sheet for the company for the fiscal year 2021, furthermore, the Board of Directors' proposal for appropriation of the company's results was adopted and discharged the members of the Board and the CEO from liability for the fiscal year 2021. Further, in accordance with the proposal submitted by the Nomination Committee, the AGM resolved that the Board of Directors shall consist of five ordinary Board members without deputy members. The Board will concist of the following members up to the AGM 2023: Peter Mattisson (Chairman of the Board), Per-Anders Johansson, Cecilia Jinert Johansson, Jörgen Brandt and Magnus Lindvall. For the same period, the Meeting elected Niclas Nordström, at the audit firm BDO Mälardalen AB, as auditor in charge. In according with the Nominating Committee’s proposal, the AGM resolved that the total fees paid to the Board, shall be 425 000 SEK, of which 125,000 shall be paid to the Chairman and SEK 75,000 shall be paid to each of those Board members elected by the AGM who are not employed by the company. It was unanimously resolved to authorize the Board to make a resolution to issue new shares. A maximum of 2,500,000 new shares may thus be issued in the period up to the AGM in 2023. Such share issue can be made with or without deviation from the current shareholders’ preferential rights. The share price shall be based on the market price at the time of the issue, with or without consideration taken to any possible market discount.
TC TECH receives the company’s first order in the biotechnology sector from Israel-based diagnostics company Picodya Technologies Ltd. (Picodya)
TC TECH Sweden AB (publ) announces that the company has received an order valued at approx. 6.5 MSEK covering production system and equipment for manufacturing of consumable products within microfluidics/diagnostics. The customer will be using TC TECH’s technology in its research and development activities, with the aim to integrate it in commercial solutions.
Picodya is an innovative diagnostics company, which develops solutions to enable rapid and cost effectiveness in vitro diagnostics directly at point of care facilities (POC). Each diagnostic testing for a patient requires the use of advanced consumable products, which needs to be manufactured with high precision to secure efficient and reliable diagnostics. ”I am pleased to present TC TECH’s first order in the biotechnology sector, and it’s also very suitably coming from a European based company. To be selected as technology provider to an innovative diagnostics company as Picodya is an interesting step for TC TECH and we will be looking forward to further developing our technology together with Picodya for applications within this market segment,” says TC TECH’s CEO Alexander Luiga. The order includes a TCP150 HPE RtS production system with expected delivery to the customer already during the end of the second quarter of 2022. The parties have also initiated discussions on a collaboration agreement to further enhance TC TECH’s production technology, with a focus on applications within microfluidics. TC TECH has a positive view on this opportunity to potentially further develop the company’s offering in this exciting market segment.
TC TECH Sweden AB (publ) publishes its interim report
TC TECH has today published its interim report for the period January 1 to March 31, 2022.
Net sales amounted to 5 795 (0) TSEK in the first quarter of 2022. In the same period, net profit/loss totalled -4 014 (-4100) TSEK. Cash flow from operating activities was -6 102 (-3 803) TSEK in the period from January 1[st] to March 31[st] 2022. Developments in the first quarter of 2022 The Board of Directors of TC TECH Sweden AB (publ) has, subject to approval at the Extraordinary General Meeting, resolved to carry out a rights issue of shares that, upon full subscription, will provide the Company with approximately SEK 24.8 million before issue costs. Developments after March 31st, 2022 TC TECH Sweden AB (publ) Held an Extraordinary General Meeting was held on 7 April. At the meeting, approximately 47% of the company's shares were represented. The EGM resolved unanimously to approve the Board of Directors' resolution on a rights issue of not more than 6,349,349 shares, entailing an increase in the share capital by a maximum of SEK 507,947.92.
Extraordinary General Meeting held by TC TECH Sweden AB (publ)
TC TECH Sweden AB (publ) held an Extraordinary General Meeting today, April 7 2022, adjacent to the company’s own premises at Pirgatan 13 in Karlshamn, Sweden. Approximately 47 % of all issued shares were represented at the EGM.
It was decided to authorize the Board to make a resolution to issue new shares. The EGM approved the board of directors decision regarding a rights issue of maximum 6,349,349 new shares, increasing the share capital with 507,947,92 SEK.
TC TECH Sweden AB (publ) publishes its Summarized Financial Statements
TC TECH has today published its summarized financial statement report for the period January 1 to December 31, 2021.
Net sales amounted to 912 (2) TSEK in the fourth quarter of 2021. In the same period, net profit/loss totalled -6 593 (-3 182) TSEK. Cash flow from operating activities was -1 363 (-1 487) TSEK in the period from October 1[st] to December 31[st] 2021. Net sales amounted to 912 (107) TSEK in the full year of 2021, while net profit/loss totalled -17 568 (-20 763) TSEK. Cash flow from operating activities was -7 445 (-14 940) TSEK in the period from January 1[st] to December 31[st] 2021. Developments after year-end, 2021 The Board of Directors of TC TECH Sweden AB (publ) has, subject to approval at the Extraordinary General Meeting, resolved to carry out a rights issue of shares that, upon full subscription, will provide the Company with approximately SEK 24.8 million before issue costs.